Allergan, Generic Cos. Battle Over Restasis Launch Plans
Companies hoping to sell generic versions of Allergan's dry-eye medication Restasis have told a New York federal court overseeing multidistrict antitrust litigation that they'll only provide information about their launch dates...To view the full article, register now.
Already a subscriber? Click here to view full article